Inhibition of Hepatitis E virus replication using short hairpin RNA (shRNA). 2010

Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. amitkothari2006@gmail.com <amitkothari2006@gmail.com>

Hepatitis E virus (HEV) is a non-enveloped, single-stranded, positive sense RNA virus, which is a major cause of water-borne hepatitis. RNA interference (RNAi) is a sequence-specific cellular antiviral defence mechanism, induced by double-stranded RNA, which we used to investigate knockdown of several genes and the 3' cis-acting element (CAE) of HEV. In the present report, shRNAs were developed against the putative helicase and replicase domains and the 3'CAE region of HEV. Production of siRNA was confirmed by northern hybridization. The possible innate response induction due to shRNA expressions was verified by transcript analysis for interferon-beta and 2',5'-oligoadenylate synthetase genes and was found to be absent. Initially, the selected shRNAs were tested for their efficiency against the respective genes/3'CAE using inhibition of fused viral subgenomic target domain-renilla luciferase reporter constructs. The effective shRNAs were studied for their inhibitory effects on HEV replication in HepG2 cells using HEV replicon and reporter replicon. RNAi mediated silencing was demonstrated by reduction of luciferase activity in subgenomic target-reporter constructs and reporter replicon. The real time PCR was used to demonstrate inhibition of native replicon replication in transfected cells. Designed shRNAs were found to be effective in inhibiting virus replication to a variable extent (45-93%).

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016752 Hepatitis E virus A positive-stranded RNA virus species, causing enterically-transmitted non-A, non-B hepatitis (HEPATITIS E). Hepatitis E virus (strain Burma),Orthohepevirus A,Paslahepevirus,Paslahepevirus balayani,Paslahepeviruses
D020868 Gene Silencing Interruption or suppression of the expression of a gene at transcriptional or translational levels. Gene Inactivation,Inactivation, Gene,Silencing, Gene
D022781 Hepatocytes The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules. Hepatic Cells,Cell, Hepatic,Cells, Hepatic,Hepatic Cell,Hepatocyte
D034741 RNA, Small Interfering Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions. RNA, Scan,Repeat-Associated siRNA,Scan RNA,Small Scan RNA,Trans-Acting siRNA,siRNA,siRNA, Repeat-Associated,siRNA, Trans-Acting,Short Hairpin RNA,Short Interfering RNA,Small Hairpin RNA,Small Interfering RNA,scnRNA,shRNA,tasiRNA,Hairpin RNA, Short,Hairpin RNA, Small,Interfering RNA, Short,Interfering RNA, Small,RNA, Short Hairpin,RNA, Short Interfering,RNA, Small Hairpin,RNA, Small Scan,Repeat Associated siRNA,Scan RNA, Small,Trans Acting siRNA,siRNA, Repeat Associated,siRNA, Trans Acting

Related Publications

Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
January 2011, Methods in molecular biology (Clifton, N.J.),
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
June 2013, Virus genes,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
May 2006, Biochemical and biophysical research communications,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
January 2010, Canadian journal of microbiology,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
March 2009, The Korean journal of hepatology,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
May 2012, Liver international : official journal of the International Association for the Study of the Liver,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
November 2008, Antiviral research,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
March 2011, Archives of virology,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
May 2003, FEBS letters,
Amit Kumar, and Subrat Kumar Panda, and Hemlata Durgapal, and Subrat Kumar Acharya, and Shagufta Rehman, and Upendra K Kar
September 2008, FEBS letters,
Copied contents to your clipboard!